The future of tumor vaccines in the post‐COVID‐19 era—Current challenges

Código QR

The future of tumor vaccines in the post‐COVID‐19 era—Current challenges

Guardado en:

Detalles Bibliográficos
Autor principal:	Panagiotis F. Christopoulos
Formato:	article
Lenguaje:	EN
Publicado:	Wiley 2021
Materias:	cancer vaccines COVID‐19 immunotherapy SARS‐CoV‐2 Immunologic diseases. Allergy RC581-607
Acceso en línea:	https://doaj.org/article/cd4fe03427214a60b37c579fe3d0d1c4
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

SARS‐CoV‐2 infection shortly after BNT162b2 vaccination results in high anti‐spike antibody levels in nursing home residents and staff
por: Doris Urlaub, et al.
Publicado: (2021)

The Bacterial Mucosal Immunotherapy MV130 Protects Against SARS-CoV-2 Infection and Improves COVID-19 Vaccines Immunogenicity
por: Carlos del Fresno, et al.
Publicado: (2021)

Recombinant protein subunit SARS-CoV-2 vaccines formulated with CoVaccine HT™ adjuvant induce broad, Th1 biased, humoral and cellular immune responses in mice
por: Chih-Yun Lai, et al.
Publicado: (2021)

COVID-19 Vaccine Boosters: The Good, the Bad, and the Ugly
por: Piotr Rzymski, et al.
Publicado: (2021)

Understanding COVID-19: From Dysregulated Immunity to Vaccination Status Quo
por: Ruby A. Escobedo, et al.
Publicado: (2021)

Effect of COVID-19 on Anti-S Antibody Response in Healthcare Workers Six Months Post-Vaccination
por: Robert Flisiak, et al.
Publicado: (2021)

Impaired Functional T-Cell Response to SARS-CoV-2 After Two Doses of BNT162b2 mRNA Vaccine in Older People
por: Julie Demaret, et al.
Publicado: (2021)

Predicted Epitope Abundance Supports Vaccine-Induced Cytotoxic Protection Against SARS-CoV-2 Variants of Concern
por: Antonio J. Martín-Galiano, et al.
Publicado: (2021)

Immune Evasive Effects of SARS-CoV-2 Variants to COVID-19 Emergency Used Vaccines
por: Yandi Zhang, et al.
Publicado: (2021)

Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated Vaccine
por: Felipe Melo-González, et al.
Publicado: (2021)

Current and future nanoparticle vaccines for COVID-19
por: Mai N. Vu, et al.
Publicado: (2021)

Counting on COVID-19 Vaccine: Insights into the Current Strategies, Progress and Future Challenges
por: Ramesh Kandimalla, et al.
Publicado: (2021)

Glycan Masking of Epitopes in the NTD and RBD of the Spike Protein Elicits Broadly Neutralizing Antibodies Against SARS-CoV-2 Variants
por: Wei-Shuo Lin, et al.
Publicado: (2021)

Pre-Existing Cross-Reactive Antibody Responses Do Not Significantly Impact Inactivated COVID-19 Vaccine-Induced Neutralization
por: Jin Wang, et al.
Publicado: (2021)

The Interaction of Natural and Vaccine-Induced Immunity with Social Distancing Predicts the Evolution of the COVID-19 Pandemic
por: Michael F. Good, et al.
Publicado: (2020)

Development of an Inactivated Vaccine against SARS CoV-2
por: Shaikh Terkis Islam Pavel, et al.
Publicado: (2021)

The Global Epidemic of the SARS-CoV-2 Delta Variant, Key Spike Mutations and Immune Escape
por: Dandan Tian, et al.
Publicado: (2021)

Side Effects of COVID-19 Pfizer-BioNTech mRNA Vaccine in Children Aged 12–18 Years in Saudi Arabia
por: Edrous Alamer, et al.
Publicado: (2021)

Increased B Cell Selection Stringency In Germinal Centers Can Explain Improved COVID-19 Vaccine Efficacies With Low Dose Prime or Delayed Boost
por: Amar K. Garg, et al.
Publicado: (2021)

Association between COVID-19 Vaccine Side Effects and Body Mass Index in Spain
por: Isabel Iguacel, et al.
Publicado: (2021)

Knowledge, Attitudes and Perception toward COVID-19 Vaccines among Adults in Jazan Province, Saudi Arabia
por: Edrous Alamer, et al.
Publicado: (2021)

Vaccinated Patients Admitted in ICU with Severe Pneumonia Due to SARS-CoV-2: A Multicenter Pilot Study
por: Ángel Estella, et al.
Publicado: (2021)

High‐resolution HLA genotyping identifies alleles associated with severe COVID‐19: A preliminary study from India
por: Ravikanth Vishnubhotla, et al.
Publicado: (2021)

Safety and Immunogenicity Analysis of a Newcastle Disease Virus (NDV-HXP-S) Expressing the Spike Protein of SARS-CoV-2 in Sprague Dawley Rats
por: Johnstone Tcheou, et al.
Publicado: (2021)

Vaccine versus Variants (3Vs): Are the COVID-19 Vaccines Effective against the Variants? A Systematic Review
por: Kadhim Hayawi, et al.
Publicado: (2021)

Immune thrombocytopenia relapse post covid-19 vaccine in young male patient
por: Hana Qasim, et al.
Publicado: (2021)

COVID-19 Breakthrough Infections and Transmission Risk: Real-World Data Analyses from Germany’s Largest Public Health Department (Cologne)
por: Lea Hsu, et al.
Publicado: (2021)

Humoral Response after Vaccination with Half-Dose of BNT162b2 in Subjects under 55 Years of Age
por: Krzysztof Lukaszuk, et al.
Publicado: (2021)

Prevalence and Factors Associated with Parents’ Non-Intention to Vaccinate Their Children and Adolescents against COVID-19 in Latin America and the Caribbean
por: Diego Urrunaga-Pastor, et al.
Publicado: (2021)

Development of Inactivated FAKHRAVAC<sup>®</sup> Vaccine against SARS-CoV-2 Virus: Preclinical Study in Animal Models
por: Soheil Ghasemi, et al.
Publicado: (2021)

CoV-RBD121-NP Vaccine Candidate Protects against Symptomatic Disease following SARS-CoV-2 Challenge in K18-hACE2 Mice and Induces Protective Responses That Prevent COVID-19-Associated Immunopathology
por: Jennifer K. DeMarco, et al.
Publicado: (2021)

The Importance of RNA-Based Vaccines in the Fight against COVID-19: An Overview
por: Bruna Aparecida Souza Machado, et al.
Publicado: (2021)

The clinical outcomes of COVID‐19 in HIV‐positive patients: A systematic review of current evidence
por: SeyedAhmad SeyedAlinaghi, et al.
Publicado: (2021)

COVID-19 pandemic: lessons learned from more than a century of pandemics and current vaccine development for pandemic control
por: Philippe Buchy, et al.
Publicado: (2021)

SARS‐CoV‐2 spike glycoprotein‐reactive T cells can be readily expanded from COVID‐19 vaccinated donors
por: Pavla Taborska, et al.
Publicado: (2021)

Organisational Model and Coverage of At-Home COVID-19 Vaccination in an Italian Urban Context
por: Elettra Carini, et al.
Publicado: (2021)

Investigating Adherence to COVID-19 Vaccination and Serum Antibody Concentration among Hospital Workers—The Experience of an Italian Private Hospital
por: Guglielmo Forgeschi, et al.
Publicado: (2021)

Complement Mediated Hemolytic Anemias in the COVID-19 Era: Case Series and Review of the Literature
por: Bruno Fattizzo, et al.
Publicado: (2021)

Willingness to Receive the Booster COVID-19 Vaccine Dose in Poland
por: Piotr Rzymski, et al.
Publicado: (2021)

Understanding the Secret of SARS-CoV-2 Variants of Concern/Interest and Immune Escape
por: Fuxing Lou, et al.
Publicado: (2021)